Skip to main content

Table 1 The expression of LncRNA in PC

From: Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star

LncRNA

Cytology

Location

Expression

Function in tumorigenesis

Reference(PMID)

PCGEM1

2q32.2

PCa Tissues,LNCaP NIH3T3 Nuclear

+

Oncogene

11050243, 14724589, 27976428

PCAT1

8q24.2

PCa Tissues, DU145 Cytoplasma

+

Oncogene

24473064

MALAT1

11q13.1

PCa Tissues, Urinary

+

Oncogene/Diagnosis and Prognosis marker

23845456, 25526020

PVT1

8q24.21

PCa Tissues

+

Oncogene

27794184

GAS5

1q25.1

PCa Tissues

–

Tumor suppressor

27743383

CTBP1-AS

4p16.3

VCaP Nucleus

+

Oncogene

23644382

PCA3

9q21.22

Peripheral Blood

+

Diagnosis marker

27743381

SChLAP1

2q31.3

PCa Tissues

+

Metastasis/Prognosis marker

25499224

LINC00963

9q34.11

LNCap cells

+

Metastasis

24691949

SOCS2-AS1

12q22

PCa Tissues

+

Oncogene

28241429, 27342770

lncRNA FR0348383

–

PCa Tissues

+

Diagnosis and Prognosis marker

28272371

lnc-MX1–1

21q22.3

PCa Tissues

+

Prognosis marker

26797783, 26797523

PCAT-14

22q11.23

22Rv1 VCaP Nucleus, Plasma

+

Prognosis marker

27460352, 27566105

lincRNA-p21

upstream of CDKN1A

Urine Exosomes

–

Tumor suppressor/Prognosis marker

28272371, 27976420, 25999983

HCG11

6q22.2

PCa Tissues

–

Prognosis marker

27522256

LncRNA-ATB

14

PCa Tissues

+

Treatment target/Prognosis marker

27176634

UCA1

19p13.12

PCa Tissues

+

Prognosis marker

27902466

NEAT1

11q13.1

PCa Tissues

+

Prognosis/Predictive marker

28241429

DRAIC

15q23

LNCap Cytoplasma

–

Tumor suppressor

26200579

Lncrna SNHG1

–

PCa Tissues

+

Oncogene

28400279

Lncrna HOXD-AS1

2q31.1

PCa Tissues

+

Oncogene

28487115

CCAT-2

8q24.22

PCa Tissues

+

Prognosis marker

27558961

HOTAIR

12q13.13

PCa Tissues, CRPC cell Cytoplasma

+

Oncogene/Prognosis marker

26411689

MEG3

14q32.3

PCa Tissues

–

Tumor suppressor

26610246, 28241429

H19

11p15.5

M12 Cytoplasma

–

Tumor suppressor

24988946

PCAT-18

18q11.2

PCa Tissues, Plasma

+

Diagnosis marker/Treatment target

24519926, 28272371

DANCR

4q12

PCa Tissues

+

Metastasis

27191265

PCAT-29

15q23

LNCap Nucleus

–

Tumor suppressor

25200579

LINC01296

14q11.2

PC cell Nucleus, Cytoplasma

+

Metastasis/Treatment target/Prognosis marker

28392705, 28341852

POTEF-AS1

2q21.2

PCa Tissues

+

Oncogene

28032932

GLIDR

9p12

PCa Tissues

+

Oncogene

28211799

PCAT-5

10p11.21

PCa Tissues

+

Oncogene

26282172

THBS4–003

5p14.1

PCa Tissues

+

Metastasis

27357608

lncRNA LOC400891

–

PCa Tissues

+

Prognosis marker

26797783

  1. Upregulation:+; Downregulaition: -